Presentation is loading. Please wait.

Presentation is loading. Please wait.

Neurotransmitters, Neurotransmitter receptors and their effects

Similar presentations


Presentation on theme: "Neurotransmitters, Neurotransmitter receptors and their effects"— Presentation transcript:

1 Neurotransmitters, Neurotransmitter receptors and their effects
We’re talking signals and what they mean to a neuron! What happens if we block signals? No specific chapter reading for this.....stick to the slides!

2 General Sequence of Events at Chemical Synapses
NTS synthesis and storage in presynaptic cell NTS release by exocytosis (Ca++ triggered event)‏ Diffusion across cleft NTS reversibly binds to receptors (LGC) and opens gates, allowing ion diffusion NTS removal from synapse (destruction, diffusion away)‏ NTS reuptake by presynaptic cell for recycling VOCC Ca+2

3 NTS Action NT diffuses across synaptic cleft to bind to receptor (LGC) on postsynaptic membrane Can generate an electric signal there (EPSP’s or IPSP’s)‏ These are graded potentials (more channels, more charge flux)‏ Effect depends which ions are allowed to diffuse across membrane, how many and for how long. Effect depends on the selectivity of the channel. What if….. the LGC are….. Na+ selective K+ selective Cl- selective What happens to the voltage on the postsynaptic cell? Is it an EPSP or an IPSP?

4 Neurotransmitters (NTs)‏
The substance must be present within the presynaptic neuron Must be released in response to presynaptic depolarization, which must occur in a calcium dependent manner Specific receptors must be present on the postsynaptic cell NT must be removed to allow another cycle of NT release, binding and signal transmission Removal: reuptake by presynaptic nerve or glia or degradation by specific enzymes or a combination of these

5 Small molecule neurotransmitters
Acetylcholine (ACh)‏ ACh (“cholinergic”)‏ Amino Acid Neurotransmitters Glutamate Aspartate GABA Glycine Catecholamines Norepinephrine Epinephrine (“adrenergics”)‏ Dopamine Indoleamine Serotonin Imidazolamine Histamine Peptide Neurotransmitters (usually 3-30 aa’s long)‏ Met-enkephalin, vasopressin (ADH), many others

6 Acetylcholine Used in NMJs
Sympathetic and parasympathetic ganglia in PNS Acetylcholine esterase (AChE)‏ “cholinergic” neurons have ChAT enzyme (choline acetyl transferase

7 Glutamate Very important in CNS Nearly all excitatory neurons use it
Antagonists to Glutamate receptor help stop neuronal death after stroke Too much- excitotoxicity due to unregulated calcium influx Too little, leads to psychosis (delusional, paranoid, lack of contact with reality

8 GABA and Glycine Major inhibitory neurotransmitter in CNS
Decreased GABA- seizures Anticonvulsants target GABA receptors or act as GABA agonists Valium- increases transmission of GABA at synapses Benzodiazepines and ethanol trigger GABA receptors……use benzodiazepines during ethanol detox. Glycine- also inhibitory Mostly in spinal cord and brainstem motor neurons

9 Catecholamines Derived from amino acid tyrosine - common precursor
Phenylalanine hydroxylase phenylalanine Catecholamines Derived from amino acid tyrosine - common precursor Removed by reuptake into terminals or surrounding glial cells via sodium dependent transporter Mono-amine oxidase (MAO) and catechol o- methyltransferase (COMT) degrade catecholamines Anti-anxiety agents- MAO- inhibitors DO NOT MIX SYMPATHOMIMETICS WITH MAOI’s!

10 DISORDER OF PHENYLALANINE METABOLISM Phenylketonuria (PKU)‏
A genetic, autosomal recessive disorder (1:20,000 births)‏ Lack of enzyme phenylalanine hydroxylase Inability to convert phenylalanine (aa) from the diet to tyrosine (aa)‏ Accumulation of breakdown products of excess phenylalanine leads to neuronal degeneration, seizures, poor motor development and irreversible mental retardation in a developing child. Testing at birth in many states, also CA. Heel stick blood sample Prevented by dietary restriction on phenylalanine. No whole protein; source of all aa’s minus this one. At least through to adulthood, while nervous system is developing. Maternal PKU: what is it?

11 Dopamine Parkinson’s Disease (Parkinsonism)‏
Loss of dopamine from neurons in substantia nigra of midbrain Resting tremor, “pill rolling”, bradykinesia, gait Treat with L-dopa. (Crosses BBB) or MAO inhibitors Side effects (hallucinations, motor)‏ The Case of the Frozen Addicts, by Langston, J. W

12 Serotonin Synthesized from tryptophan
Also known as 5- hydroxytryptamine (5-HT)‏ SSRI’- selective serotonin reuptake inhibitors are anti-depressant drugs Ecstasy causes more release! Mood elevator, “feel- good” neurotransmitter

13

14 Ionotropic Receptors Nicotinic AChR Serotonin Glutamate GABAA Glycine

15 Metabotropic Receptors
Muscarinic Acetylcholine receptor Amanita muscaria Parasympathetic effectors stimulated Increased saliva, tears, diarrhea Antidote is atropine. alpha and Beta-Adrenergic receptor alpha1-receptors: bind G protein, activate inositol triphosphate and diacylglycerol as second messengers alpha2 -receptors: bind the inhibitory G-protein, restrain the adenyl cylase system, reduce cAMP levels beta-receptors: bind adenylate cyclase-stimulating G-protein, use cAMP as second messenger. Some glutamate receptors, many, many others

16 Major Intracellular Transduction Pathways Used by metabotropic receptors
Signaling molecule Cell surface receptor G protein Effector protein Second messenger cAMP IP3/D AG Late effectors Target protein cAMP Pathway IP3 Pathway

17 Signaling by GPCRs

18 Adenylate cyclase and guanylate cyclase
Make cyclic AMP and cyclic GMP

19 Protein kinase A dissociates when activated by cAMP
Regulatory subunit Catalytic subunit - Add/remove phosphates to/from enzymes to activate or deactivate them

20 Phosphatases remove phosphorylation; kinases add
Better to think in terms of changes in activity rather than activation (i.e. always basal state of activation)‏

21 NE adrenergic receptor mechanism  C GTP R R C PKA R C  cAMP

22 Inositol Trisphosphate & DAG

23 Aspects of IP3 signaling
Production of IP3 Release of Intracellular Calcium PKC Aspects of IP3 signaling

24 NT postsynaptic response and gene expression
Open channels Alter gene expression Second messenger activation can lead to phosphorylation of proteins that in turn regulate gene transcription

25 Spastic paralysis vs. flaccid paralysis
Drugs and Toxins Spastic paralysis vs. flaccid paralysis

26 Sodium VGC Blockers Lidocaine- used as anesthesia
Tetrodotoxin-puffer fish and newts (TTX)‏ Saxitoxin- caused by red tide; dinoflagellate; accumulates in shellfish (SXT)‏ Flaccid paralysis

27 Vesicle blockers Clostridium botulinum:
It is a protease that breaks down one of the fusion proteins (docking proteins that anchor the vesicle to the membrane) Inhibits neurotransmitter release Undercooked turkey; dented cans Flaccid paralysis “BOTOX”

28 mACH-R blocker/ competitor
Atropine Flaccid paralysis Smooth muscle, heart, and glands

29 nACH-R blocker/ competitor
Curare From tree sap Causes flaccid paralysis Large dose: asphyxiation

30 AchE Blockers Neostigmine Physostigmine Spastic paralysis
Myasthenia Gravis- ptosis

31 AchE irreversible inhibitor
DFP- di-isopropyl fluorophosphates Sarin Spastic paralysis Ventilator until AchE turnover

32 Inhibitory Neuron Blockers
Tetanus exotoxin Blocks release of inhibitory neurotransmitters Muscles can’t relax Spastic paralysis Opposing flexor and extensor muscles contract

33 Spider Venom Black widow: causes Ach release
Lack of inhibitory neurotransmitters Spastic paralysis Brazilian Wandering Spider and Viagra? Spider venom increases NO release Viagra blocks enzyme that degrades NO Most venomous of all spiders/ more human deaths


Download ppt "Neurotransmitters, Neurotransmitter receptors and their effects"

Similar presentations


Ads by Google